126 related articles for article (PubMed ID: 24038392)
21. Two novel GALNT3 mutations in familial tumoral calcinosis.
Garringer HJ; Mortazavi SM; Esteghamat F; Malekpour M; Boztepe H; Tanakol R; Davis SI; White KE
Am J Med Genet A; 2007 Oct; 143A(20):2390-6. PubMed ID: 17853462
[TBL] [Abstract][Full Text] [Related]
22. Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer.
Evans DR; Venkitachalam S; Revoredo L; Dohey AT; Clarke E; Pennell JJ; Powell AE; Quinn E; Ravi L; Gerken TA; Green JS; Woods MO; Guda K
Hum Mutat; 2018 Aug; 39(8):1092-1101. PubMed ID: 29749045
[TBL] [Abstract][Full Text] [Related]
23. GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis.
Demellawy DE; Chang N; de Nanassy J; Nasr A
Scand J Rheumatol; 2015; 44(2):170-2. PubMed ID: 25351881
[No Abstract] [Full Text] [Related]
24. A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification.
Chefetz I; Heller R; Galli-Tsinopoulou A; Richard G; Wollnik B; Indelman M; Koerber F; Topaz O; Bergman R; Sprecher E; Schoenau E
Hum Genet; 2005 Nov; 118(2):261-6. PubMed ID: 16151858
[TBL] [Abstract][Full Text] [Related]
25. Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.
Peluso G; Tian E; Abusleme L; Munemasa T; Mukaibo T; Ten Hagen KG
J Biol Chem; 2020 Jan; 295(5):1411-1425. PubMed ID: 31882545
[TBL] [Abstract][Full Text] [Related]
26. Tumoral calcinosis due to GALNT3 C.516-2A >T mutation in a black African family.
Laleye A; Alao MJ; Gbessi G; Adjagba M; Marche M; Coupry I; Redonnet-Vernhet I; Lepreux S; Ayivi B; Darboux RB; Lacombe D; Arveiler B
Genet Couns; 2008; 19(2):183-92. PubMed ID: 18618993
[TBL] [Abstract][Full Text] [Related]
27. [Familial tumoral calcinosis with hyperphosphatemia is heterogeneous and associated with mutations in GALNT3 or FGF-23].
Dereure O
Ann Dermatol Venereol; 2006 Apr; 133(4):408. PubMed ID: 16733465
[No Abstract] [Full Text] [Related]
28. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
[TBL] [Abstract][Full Text] [Related]
29. Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis.
Barbieri AM; Filopanti M; Bua G; Beck-Peccoz P
J Hum Genet; 2007; 52(5):464-468. PubMed ID: 17351710
[TBL] [Abstract][Full Text] [Related]
30. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
J Clin Endocrinol Metab; 2006 Oct; 91(10):4037-42. PubMed ID: 16868048
[TBL] [Abstract][Full Text] [Related]
31. Root anomalies and dentin dysplasia in autosomal recessive hyperphosphatemic familial tumoral calcinosis (HFTC).
Vieira AR; Lee M; Vairo F; Loguercio Leite JC; Munerato MC; Visioli F; D'Ávila SR; Wang SK; Choi M; Simmer JP; Hu JC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Dec; 120(6):e235-9. PubMed ID: 26337219
[TBL] [Abstract][Full Text] [Related]
32. Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred.
Specktor P; Cooper JG; Indelman M; Sprecher E
J Hum Genet; 2006; 51(5):487-490. PubMed ID: 16528452
[TBL] [Abstract][Full Text] [Related]
33. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.
Benet-Pagès A; Orlik P; Strom TM; Lorenz-Depiereux B
Hum Mol Genet; 2005 Feb; 14(3):385-90. PubMed ID: 15590700
[TBL] [Abstract][Full Text] [Related]
34. Reply to ultrastructural study of the clinically uninvolved skin in familial tumoral calcinosis caused by mutations in GALNT3.
Bergman R; Topaz O; Iancu TC; Sprecher E
Am J Dermatopathol; 2006 Aug; 28(4):372-3. PubMed ID: 16871046
[No Abstract] [Full Text] [Related]
35. A new missense mutation in FGF23 gene in a male with hyperostosis-hyperphosphatemia syndrome (HHS).
Abbasi F; Ghafouri-Fard S; Javaheri M; Dideban A; Ebrahimi A; Ebrahim-Habibi A
Gene; 2014 Jun; 542(2):269-71. PubMed ID: 24680727
[TBL] [Abstract][Full Text] [Related]
36. Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23.
Frishberg Y; Ito N; Rinat C; Yamazaki Y; Feinstein S; Urakawa I; Navon-Elkan P; Becker-Cohen R; Yamashita T; Araya K; Igarashi T; Fujita T; Fukumoto S
J Bone Miner Res; 2007 Feb; 22(2):235-42. PubMed ID: 17129170
[TBL] [Abstract][Full Text] [Related]
37. Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization.
Masi L; Beltrami G; Ottanelli S; Franceschelli F; Gozzini A; Zonefrati R; Galli G; Ciuffi S; Mavilia C; Giusti F; Marcucci G; Cioppi F; Colli E; Fossi C; Franchi A; Casentini C; Capanna R; Brandi ML
Calcif Tissue Int; 2015 May; 96(5):438-52. PubMed ID: 25899975
[TBL] [Abstract][Full Text] [Related]
38. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
Lorca V; Rueda D; Martín-Morales L; Poves C; Fernández-Aceñero MJ; Ruiz-Ponte C; Llovet P; Marrupe D; García-Barberán V; García-Paredes B; Pérez-Segura P; de la Hoya M; Díaz-Rubio E; Caldés T; Garre P
PLoS One; 2017; 12(11):e0187312. PubMed ID: 29095867
[TBL] [Abstract][Full Text] [Related]
39. Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family.
Campagnoli MF; Pucci A; Garelli E; Carando A; Defilippi C; Lala R; Ingrosso G; Dianzani I; Forni M; Ramenghi U
J Clin Pathol; 2006 Apr; 59(4):440-2. PubMed ID: 16567474
[TBL] [Abstract][Full Text] [Related]
40. Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome.
Gok F; Chefetz I; Indelman M; Kocaoglu M; Sprecher E
Acta Orthop; 2009 Feb; 80(1):131-4. PubMed ID: 19297793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
